Canada markets open in 2 hours 18 minutes

ESSA Pharma Inc. (EPIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.43+0.29 (+4.72%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 283.57M
Enterprise Value 141.82M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.52

Trading Information

Stock Price History

Beta (5Y Monthly) 1.69
52-Week Change 3125.61%
S&P500 52-Week Change 323.10%
52 Week High 311.67
52 Week Low 32.56
50-Day Moving Average 38.15
200-Day Moving Average 35.79

Share Statistics

Avg Vol (3 month) 3123.75k
Avg Vol (10 day) 386.08k
Shares Outstanding 544.24M
Implied Shares Outstanding 644.24M
Float 824.61M
% Held by Insiders 12.28%
% Held by Institutions 178.67%
Shares Short (Apr 15, 2024) 4769.26k
Short Ratio (Apr 15, 2024) 412.6
Short % of Float (Apr 15, 2024) 42.89%
Short % of Shares Outstanding (Apr 15, 2024) 41.74%
Shares Short (prior month Mar 15, 2024) 4928.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 25, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Apr 25, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-12.87%
Return on Equity (ttm)-17.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-25.8M
Diluted EPS (ttm)-0.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)142.12M
Total Cash Per Share (mrq)3.21
Total Debt (mrq)374.83k
Total Debt/Equity (mrq)0.27%
Current Ratio (mrq)40.75
Book Value Per Share (mrq)3.18

Cash Flow Statement

Operating Cash Flow (ttm)-22.19M
Levered Free Cash Flow (ttm)-15.17M